News sentiment analysis for TMO
Sentiment chart
2026-01-14
Should You Continue to Hold Thermo Fisher Stock in Your Portfolio Now?
Description: TMO ramps up acquisitions and product launches to drive growth, but heavy debt and currency headwinds raise questions for long-term holders.
2026-01-13
JPM26: ThermoFisher ‘very positive’ on strategic M&A as deals expand capabilities
Description: ThermoFisher expects revenue growth in the 3–6% range for 2026 and 2027, and a growth rate of 7% or more in 2028 and beyond.
Thermo Fisher wins contracts as pharma shifts production to US, CEO says
Description: By Sneha S K and Gnaneshwar Rajan Jan 13 (Reuters) - Thermo Fisher Scientific's pharmaceutical services business has won a number of contracts to help its customers move production from Europe or Asia to the U., the medical equipment maker's CEO, Marc Casper, said on Tuesday.
2026-01-12
Nvidia Partners With Biotech Firms On AI Drug Discovery
Description: Nvidia announced AI partnerships with two biotech firms to transform the way lifesaving drugs are discovered and manufactured.
Thermo Fisher Scientific Announces Strategic Collaboration With NVIDIA Leveraging AI to Advance Scientific Instrumentation and Accelerate Laboratory Performance
Description: WALTHAM, Mass., January 12, 2026--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced a strategic collaboration with NVIDIA to power AI-based solutions and laboratory automation at scale. The effort will leverage the NVIDIA Artificial Intelligence (AI) platform and Thermo Fisher Scientific solutions to progressively increase the automation, accuracy and speed of laboratories. The companies are working together to evolve the digital foundation that powers sci
Nvidia Stock Closes Flat. The Chip Maker Is Launching an AI Lab with Eli Lilly.
Description: Nvidia stock was languishing Monday despite news of a partnership with pharmaceutical company Eli Lilly The chip company’s investors remain focused progress on sales in China and the health of the wider artificial-intelligence sector. The stock is down 1.8% over the past month, as a flurry of robotics and autonomous-driving related announcements at the CES trade show, formerly known as the Consumer Electronics Show, failed to provide a boost. Nvidia said Monday that it was joining with Eli Lilly to fund an AI lab with an investment of up to $1 billion over five years to build models for biology and chemistry.
CIO sees healthcare as a great potential investment in 2026
Description: <body><p>STORY: Ahlsten says healthcare stands out as an area where fundamentals remain attractive, even as much of the market's gains have been concentrated in a handful of large technology stocks.</p><p>"Health care has got great demographics behind it and double digit earnings growth for a lot of companies and importantly the valuations are reasonable," he says.</p><p>"Companies like Danaher and Thermo Fisher, Life Sciences, life sciences tools. We're going to see a lot of research coming out of all this innovation and technology, personalized medicine and we think those areas are poised to do very, very well in the years ahead."</p></body>
TetraScience Announces Collaboration with Thermo Fisher Scientific to Accelerate Scientific Data and AI Enablement Across the Laboratory
Description: TetraScience, the Scientific Data and AI company, today announced a collaboration with Thermo Fisher Scientific Inc., the world leader in serving science, with a goal of accelerating AI across biopharma R&D and manufacturing by transforming scientific data into AI-native form and developing intelligent workflows at scale.
NVIDIA BioNeMo Platform Adopted by Life Sciences Leaders to Accelerate AI-Driven Drug Discovery
Description: NVIDIA BioNeMo NVIDIA today announced a major expansion of NVIDIA BioNeMo, an open development platform that enables lab-in-the-loop workflows to develop breakthroughs in AI-driven biology and drug discovery. News Summary: Lilly and NVIDIA launch AI co-innovation lab to tackle drug discovery challenges.NVIDIA collaborates with Thermo Fisher to build autonomous lab infrastructure for scalable scientific discovery.Chai Discovery, Basecamp Research, Boltz and ecosystem leaders connect NVIDIA BioNeM
Thermo Fisher Chief Operating Officer Michel Lagarde Leaving Company
Description: Thermo Fisher Scientific’s number-two executive, Michel Lagarde, is leaving the life-sciences giant to pursue another opportunity.
Henry Schein Names Frederick M. Lowery as Chief Executive Officer
Description: MELVILLE, N.Y., January 12, 2026--Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of healthcare solutions to office-based dental and medical professionals, today announced the appointment of Frederick M. Lowery as its new Chief Executive Officer ("CEO"), effective March 2, 2026, at which time he will join the Board of Directors. Mr. Lowery succeeds Stanley M. Bergman, who will step down as CEO after 35 years and continue to serve as Chairman of the Board to ensure a smooth and ef
2026-01-11
2026-01-10
2026-01-09
HSBC lists 11 potential U.S. outperformers heading into earnings
Description: Investing.com -- HSBC has identified 11 U.S. stocks that could outperform as the fourth-quarter earnings season begins, highlighting companies with strong competitive positions, improving fundamentals and exposure to long-term themes.
2026-01-08
Veterinary Infectious Disease Diagnostics Market Forecast, 2025-2035, Featuring IDEXX Labs, Zoetis, Thermo Fisher Scientific, Virbac, bioMerieux and More
Description: Dublin, Jan. 08, 2026 (GLOBE NEWSWIRE) -- The "Veterinary Infectious Disease Diagnostics Market - A Global and Regional Analysis: Focus on Technology, Product, Animal Type, Infection Type, End user, Country, and Region - Analysis and Forecast, 2025-2035" has been added to ResearchAndMarkets.com's offering.One of the key drivers of the veterinary infectious disease diagnostics market is the rising prevalence of zoonotic diseases. Zoonotic diseases those transmitted from animals to humans pose sig
$443.6 Bn Microtome Global Market Trends, Opportunities and Strategies, 2019-2024, 2025-2029F, 2034F: Top 10 Players Hold 26.56% Share Led by Danaher, Thermo Fisher Scientific, and Sakura Finetek
Description: Key opportunities in the microtome market lie in expanding technical centers for innovation, focusing on next-gen microtomes and automation to enhance precision, and tapping into emerging markets. Growth is driven by disease diagnosis and drug discovery needs, with the accessories and fully automated segments showing promise. Microtome Market Microtome Market Dublin, Jan. 08, 2026 (GLOBE NEWSWIRE) -- The "Microtome Global Market Opportunities and Strategies to 2034" has been added to ResearchAnd
How The Narrative Around Thermo Fisher Scientific (TMO) Is Shifting After Q3 And New Forecasts
Description: Why Thermo Fisher’s Fair Value Estimate Just Nudged Higher Thermo Fisher Scientific’s fair value estimate has been revised slightly higher, moving from about US$625.87 to roughly US$641.57, while the discount rate and long term revenue growth assumptions are essentially unchanged. This reflects Street research that has turned somewhat more constructive after a Q3 update described as strong or in line, with analysts highlighting consistent execution, Thermo Fisher’s scale in life science...
2026-01-07
Biotechnology Instruments Market Projected to Reach US$ 141.70 Billion by 2035 | Astute Analytica
Description: The market offers explosive potential as biology transitions to factory-scale production. Anchored by the USD 100 genome and high-margin consumables, the sector promises sustained scalability. Massive infrastructure investments, like Eli Lilly’s USD 4.5 billion campus, confirm a lucrative, long-term trajectory.Chicago, Jan. 07, 2026 (GLOBE NEWSWIRE) -- The global biotechnology instruments market size stood at USD 92.12 billion in 2025 and is expected to reach USD 141.70 billion by 2035 with a 4.
Thermo Fisher Scientific (TMO) Valuation Check As New Obesity Registry And Key Updates Draw Investor Focus
Description: Thermo Fisher Scientific (TMO) is back in focus after enrolling the first patient in its PPD CorEvitas Obesity Registry, a real world data effort that intersects directly with obesity therapies and long term health outcomes. See our latest analysis for Thermo Fisher Scientific. The new obesity registry has arrived at a time when Thermo Fisher Scientific’s share price has been firming, with a 90 day share price return of 15.76% and a 1 year total shareholder return of 14.16%. This suggests...
2026-01-06
Will Thermo Fisher (TMO) Beat Estimates Again in Its Next Earnings Report?
Description: Thermo Fisher (TMO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Here's How Much You'd Have If You Invested $1000 in Thermo Fisher Scientific a Decade Ago
Description: Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
Thermo Fisher Scientific to Present at the J.P. Morgan 2026 Healthcare Conference
Description: WALTHAM, Mass., January 06, 2026--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present at the J.P. Morgan 2026 Healthcare Conference on Tuesday, January 13, 2026, at 11:15 a.m. (ET).
Thermo Fisher Scientific Launches CorEvitas Obesity Registry to Advance Real-World Evidence in Treatment Outcomes
Description: WALTHAM, Mass., January 06, 2026--Thermo Fisher Scientific launches CorEvitas Obesity Registry to advance real-world evidence in treatment outcomes.
2026-01-05
Will Thermo Fisher’s Pharma Demand Outlook and Clario Deal Reframe Its Investment Story (TMO)?
Description: In recent days, Thermo Fisher Scientific has moved closer to its upcoming January 29, 2026 fourth-quarter and full-year 2025 earnings release, with investors closely tracking management’s pending updates on pharma and biotech demand, margins, and the progress of its planned Clario acquisition. This focus on commentary about high-end instrument demand, customer budgets, and margin trends highlights how much weight investors place on Thermo Fisher’s outlook and operating efficiency. Next,...
Beat the Market the Zacks Way: LATAM, General Motors, Amgen in Focus
Description: LTM, GM and AMGN highlight Zacks' recent stock-picking wins, delivering notable gains across airlines, autos and biotech despite choppy markets.
2026-01-04
2026-01-03
2026-01-02
2026-01-01
2025-12-31
Here’s What Lifted Thermo Fisher Scientific (TMO) in Q3
Description: Bristol Gate Capital Partners, an investment management company, published its Q3 2025 investor letter for the “US Equity Strategy”. A copy of the letter can be downloaded here. The strategy underperformed the benchmark, the S&P 500® Total Return Index, this quarter, but still surpassed the index in dividend growth. The underperformance was due to a […]
2025-12-30
BofA Raises Thermo Fisher (TMO) Target as Biopharma Recovery Comes Into View
Description: Thermo Fisher Scientific Inc. (NYSE:TMO) is included among the 14 Best Pharma Dividend Stocks to Buy in 2026. On December 15, Bank of America raised its price target on Thermo Fisher Scientific Inc. (NYSE:TMO) to $700 from $650 and kept a Buy rating on the shares. The firm said it was updating price targets across its […]
Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names
Description: Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
What to Expect From Thermo Fisher Scientific's Next Quarterly Earnings Report
Description: Thermo Fisher Scientific will release its fourth-quarter earnings next month, and analysts anticipate a single-digit bottom-line growth.
2025-12-29
What Makes Thermo Fisher (TMO) a Good Investment Choice?
Description: Artisan Partners, an investment management company, released its “Artisan Value Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The equity market rally persisted in the third quarter as investors ignored tariffs, buoyed by strong corporate earnings, rising AI investment, and prospects of economic support from US fiscal policy and […]
2025-12-28
2025-12-27
2025-12-26
Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, January 29, 2026
Description: WALTHAM, Mass., December 26, 2025--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the fourth quarter and full year 2025 before the market opens on Thursday, January 29, 2026, and will hold a conference call on the same day at 8:30 a.m. ET. During the call, the company will discuss its financial performance, as well as future expectations.
2025-12-25
2025-12-24
2025-12-23
Favorable Results and Improved Guidance Lifted Thermo Fisher Scientific (TMO) in Q3
Description: Parnassus Investments, an investment management company, released the “Parnassus Core Equity Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The S&P 500 Index surged in the third quarter, driven by investor optimism that grew on expectations of monetary easing, strong consumer demand, and solid corporate earnings. The Fund (Investor […]
Thermo Fisher Scientific Insiders Sold US$3.6m Of Shares Suggesting Hesitancy
Description: In the last year, many Thermo Fisher Scientific Inc. ( NYSE:TMO ) insiders sold a substantial stake in the company...
2025-12-22
The Zacks Analyst Blog Highlights Walmart, Wells Fargo, Thermo Fisher Scientific, Seneca Foods and NetSol Technologies
Description: Walmart, Wells Fargo and Thermo Fisher anchor Zacks' latest Analyst Blog as strong execution and innovation drive outperformance.
Beat the Market the Zacks Way: Micron, Credo, Coca Cola in Focus
Description: Micron, Credo and Coca-Cola headline Zacks' latest wins, with select portfolios and focus lists posting sharp gains despite a mixed market week.
TMO Stock May Benefit From PPD CorEvitas Alzheimer's Registry Launch
Description: Thermo Fisher launches a global PPD CorEvitas Alzheimer's registry, enrolling its first patient to generate real-world safety and effectiveness data.
2025-12-21
2025-12-20
Analysts See 12% Upside To Thermo Fisher Scientific Inc. (TMO)
Description: Thermo Fisher Scientific Inc. (NYSE:TMO) is among the 14 Best S&P 500 Stocks to Buy Now. As of the close of business on December 17, Wall Street analysts have a consensus Strong Buy rating on the stock, with a one-year average share price target of $640.30, representing an upside of 12%. Recent analyst updates include Wells […]
2025-12-19
Top Stock Reports for Walmart, Wells Fargo & Thermo Fisher Scientific
Description: Walmart's omnichannel execution, strong comps and expanding higher-margin businesses are driving outperformance despite cost pressures and tariff risks.
How Investors May Respond To Thermo Fisher Scientific (TMO) Expanding Alzheimer’s Registry And Bioprocessing Tools
Description: Earlier this week, Thermo Fisher Scientific reported the first patient enrollment in its new international PPD CorEvitas Alzheimer’s Disease Registry and introduced next-generation Gibco Bacto CD Supreme media and feed to support higher-yield, chemically defined E. coli–based production of plasmid DNA and recombinant proteins. Together, these moves deepen Thermo Fisher’s role in real-world Alzheimer’s evidence generation while reinforcing its tools franchise in gene therapy and mRNA...
2025-12-18
Thermo Fisher Scientific Launches PPD CorEvitas Alzheimer’s Disease Registry to Advance Real-World Evidence in Neurodegenerative Care
Description: WALTHAM, Mass., December 18, 2025--Thermo Fisher Scientific Launches PPD CorEvitas Alzheimer’s Disease Registry to Advance Real-World Evidence in Neurodegenerative Care.
2025-12-17
North America Poised for Highest Growth in Microplastic Analysis Market with 8.5% CAGR
Description: The global microplastic analysis market is set to grow from USD 266.9 million in 2025 to USD 383.1 million by 2030 at a CAGR of 7.5%. Growth is driven by increased research funding, rising proteomics research, and heightened awareness of microplastic pollution risks. The instruments segment will dominate the market in 2025, with substantial demand for reagents and consumables fueled by regulatory pressures. The water testing segment is experiencing rapid growth due to stricter water quality regu
2025-12-16
TMO Stock Set to Gain From the Expansion of Gibco Bacto Portfolio
Description: Thermo Fisher expands its Gibco Bacto CD portfolio with new formulations aimed at boosting E. coli-based plasmid DNA and protein production efficiency.
2025-12-15
OlivePoint Capital Acquires 3900 Paramount Parkway in Raleigh–Durham, Expanding Its High-Conviction Office Special Situations Strategy
Description: LOS ANGELES, December 15, 2025--OlivePoint acquires a Class A Raleigh office 100% leased to PPD/Thermo Fisher, highlighting its strategy to target mispriced, credit-backed assets.
Thermo Fisher Scientific Expands Gibco™ Bacto™ Portfolio with Next-Generation, Chemically Defined Media to Boost E. coli Biomanufacturing Productivity
Description: WALTHAM, Mass., December 15, 2025--Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of Gibco™ Bacto™ CD Supreme FPM Plus and Gibco™ Bacto™ CD Supreme Feed (2X), two next-generation chemically-defined formulations that expand the Gibco™ Bacto™ CD portfolio to enhance and simplify plasmid DNA and recombinant protein production using Escherichia coli (E. coli).
2025-12-14
Taking Stock of Thermo Fisher Scientific (TMO) Valuation After Analyst Upgrades and Bioprocessing, Cardio Testing Moves
Description: Thermo Fisher Scientific (TMO) just picked up fresh buy ratings on the back of its Asian bioprocessing expansion and a new cardiovascular risk testing partnership, and investors are treating that combination as a meaningful confidence signal. See our latest analysis for Thermo Fisher Scientific. Although Thermo Fisher’s share price is slightly softer in the very short term, a roughly 21 percent 90 day share price return suggests momentum is rebuilding as investors reprice its Asia buildout...
2025-12-13
2025-12-12
Becton Dickinson, Bio-Rad, and Thermo Fisher Propel Safety and Automation in Blood Collection Tubes—New Market Report Highlights $7Billion Opportunity
Description: The blood collection tubes market presents opportunities through innovation in automated systems, advanced materials, and digital traceability to enhance workflow efficiency and compliance. Demand is driven by personalized medicine, diagnostic volume growth, and regulatory needs, with a focus on agility and regional adaptation. Blood Collection Tubes Market Blood Collection Tubes Market Dublin, Dec. 12, 2025 (GLOBE NEWSWIRE) -- The "Blood Collection Tubes Market - Global Forecast 2025-2032" has
Morgan Stanley Analyst Is Bullish On Thermo Fisher Scientific Inc. (TMO)
Description: Thermo Fisher Scientific Inc. (NYSE:TMO) is among the 13 Best Nanotechnology Stocks to Buy Now. According to The Fly, on December 2, 2025, Morgan Stanley analyst Kallum Titchmarsh established a price objective of $670, up from $656. He initiated coverage of Thermo Fisher Scientific Inc. (NYSE:TMO) with an Overweight rating. According to Titchmarsh, the end […]
Autoimmune Disease Diagnosis Market to Surge to USD 8.98 Billion by 2031
Description: The autoimmune disease diagnosis market is poised to grow from USD 5.57 billion in 2025 to USD 8.98 billion by 2031, exhibiting a CAGR of 8.3%. Key growth drivers include rising autoimmune disorder prevalence, increased awareness of early detection, and technological advances. Systemic autoimmune diseases lead in market share due to conditions like rheumatoid arthritis and lupus necessitating complex diagnostics. The Asia Pacific region is the fastest-growing, driven by healthcare advancements.
2025-12-11
PayPal downgraded, Roku upgraded: Wall Street's top analyst calls
Description: PayPal downgraded, Roku upgraded: Wall Street's top analyst calls
2025-12-10
Synopsys upgraded, Warner Bros. downgraded: Wall Street’s top analyst calls
Description: The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors need to know, as compiled by The Fly.Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential Top 5 Upgrades: Rosenblatt upgr
2025-12-09
Is Thermo Fisher Still Attractively Priced After Recent Share Price Dip In 2025?
Description: Wondering if Thermo Fisher Scientific is still a smart buy at today’s price, or if most of the upside has already been captured? Let us unpack what the market might be missing in the valuation. The stock is up 7.8% year to date and 5.5% over the last 12 months, even after a recent 3.0% dip in the past week and a modest 1.6% slide over the last month. This hints that sentiment is positive but still a bit cautious. Recent headlines have focused on Thermo Fisher’s steady deal making in life...
Synopsys upgraded, Warner Bros. downgraded: Wall Street's top analyst calls
Description: Synopsys upgraded, Warner Bros. downgraded: Wall Street's top analyst calls
Goldman Sachs starts Life Sciences Tools coverage, rates these 3 stocks at Buy
Description: Investing.com -- Goldman Sachs has launched coverage of the Life Sciences Tools sector with a selective stance, arguing that the group should ultimately “return to their historic market growth rate of ~5%,” but only as certain end markets recover faster than others.
DNA Diagnostics Market Projected to Surge by 66% to USD 21.69 Billion by 2030
Description: The DNA Diagnostics Market is set to surge from USD 13.07 billion in 2024 to USD 21.69 billion by 2030, growing at a CAGR of 8.81%. Key trends driving this growth include the emergence of liquid biopsies, the rise of direct-to-consumer testing, the shift to smart bioinformatics, and advancements in genomics and personalized medicine. Increasing genetic disorder prevalence, improved DNA sequencing technology, and expanded diagnostic applications further fuel market expansion. North America leads
2025-12-08
Beat the Market the Zacks Way: Veracyte, Las Vegas Sands, 3M in Focus
Description: Veracyte, Las Vegas Sands and 3M shine as Zacks spotlights standout stock gains and portfolio wins amid shifting market sentiment.
Patient Engagement in Genomics Research Fuels Growth in Healthcare Segment
Description: The global genomics market is set to expand from USD 47.07 billion in 2025 to USD 85.09 billion by 2030, with a CAGR of 12.6%. Driven by increased government funding, rising disease prevalence, and advances in NGS technologies, the market sees augmented application in healthcare, agriculture, and forensics. The reagents, kits, and consumables segment is projected with the highest growth, fueled by ongoing genomic experiments. Key players like Illumina and Thermo Fisher Scientific are pivotal, es
2025-12-07
2025-12-06
2025-12-05
Thermo Fisher’s New Asia Bioprocessing Network Might Change The Case For Investing In Thermo Fisher Scientific (TMO)
Description: In late 2025, Thermo Fisher Scientific expanded its bioprocessing footprint across Asia, opening a new Bioprocess Design Center in Hyderabad, India and enlarging existing hubs in Incheon, Korea and Singapore to support faster, more efficient and sustainable biologics manufacturing. This tri-hub network creates a tightly connected regional platform that gives biopharma customers local access to advanced technologies, process design expertise and training, potentially deepening Thermo Fisher’s...
2025-12-04
Why Is Waters (WAT) Up 6.9% Since Last Earnings Report?
Description: Waters (WAT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
What Made Thermo Fisher Scientific (TMO) a Solid Performer in Q3?
Description: Harding Loevner, an asset management company, released its “Global Equity Strategy” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund returned 2.62% gross (2.52% net) in the third quarter of 2025, compared to a 7.74% return for the MSCI All Country World Index and 7.36% gain for the MSCI […]
2025-12-03
TMO Stock Benefits From New Bioprocess Design Center in Asia
Description: Thermo Fisher expands its Bioprocess Design Centers across Asia, boosting biomanufacturing speed, efficiency and regional innovation.
Why Is Hologic (HOLX) Up 1% Since Last Earnings Report?
Description: Hologic (HOLX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
2025-12-02
Thermo Fisher Scientific Deepens Investment in Asia’s Biopharma Ecosystem with Expansion of Bioprocess Design Centers
Description: WALTHAM, Mass., December 02, 2025--Thermo Fisher Scientific Inc., the world leader in serving science, today announced an expansion of its bioprocessing capabilities across Asia, reinforcing its commitment to supporting the region’s rapidly growing biopharmaceutical industry. The company is introducing a new Bioprocess Design Center in Hyderabad, India, and has expanded its existing Bioprocess Design Centers in Incheon, Korea and Singapore, further strengthening a strategic regional network desi
Thermo Fisher (TMO) Raises €2.1 Billion Through Floating and Fixed-Rate Senior Notes
Description: Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the best dividend stocks to buy according to hedge funds. On November 25, Thermo Fisher reported that it had made an offering of euro-dominated notes in the principal amount of €2.1 billion. The notes are planned to be issued via Thermo Fisher Scientific (Finance I) B.V., the […]
2025-12-01
Buffer Preparation Market Trends & Forecasts Report 2025-2035 Featuring Asahi Kasei, Avantor, Canvax, Danaher, GE, HOPAX, Merck, Prepared Biologics, Sartorius, Sepragen, Thermo Fisher Scientific, ZETA
Description: Key opportunities in the buffer preparation market include expanding demand for advanced buffer systems in biopharma production, increasing preference for outsourcing to reduce costs, and growth potential in reusable equipment and liquid formulations. North America remains dominant, while Asia-Pacific exhibits high growth potential. Scale of Operation Scale of Operation Buffer Service Providers Buffer Service Providers Buffer Manufacturing Systems Buffer Manufacturing Systems Dublin, Dec. 01, 20
2025-11-30
2025-11-29
A Look At The Intrinsic Value Of Thermo Fisher Scientific Inc. (NYSE:TMO)
Description: Key Insights The projected fair value for Thermo Fisher Scientific is US$603 based on 2 Stage Free Cash Flow to Equity...
2025-11-28
North America Mass Spectrometry Market Report 2025-2033, Profiles of Agilent Technologies, Bruker, Danaher, Hitachi, JEOL, LECO, PerkinElmer, and Thermo Fisher Scientific
Description: The North America Mass Spectrometry Market is poised to surge from US$ 2.6 Billion in 2024 to US$ 4.87 Billion by 2033, driven by a 7.21% CAGR. Key growth areas include pharmaceutical, environmental analysis, and food safety sectors, powered by advancements in mass spectrometry technology enhancing sensitivity and precision. Major drivers include increased demand in the pharmaceutical and biotechnology sectors, advancements in hybrid and high-resolution technologies, and growing applications in
2025-11-27
2025-11-26
US STD Diagnostics Market Forecast and Company Analysis 2025-2033 Featuring Abbott, F. Hoffmann-La Roche, Hologic, BD and Co, Danaher, Siemens, bioMerieux, Thermo Fisher Scientific, Qiagen, Bio-Rad
Description: The United States STD Diagnostics Market is set to grow from US$ 5.06 billion in 2024 to US$ 8.49 billion by 2033, achieving a CAGR of 5.91% from 2025 to 2033. Key growth drivers include rising STD prevalence, technological advancements, increased awareness, and supportive government initiatives. Rapid point-of-care tests and molecular diagnostics are gaining traction, while high costs and regulatory hurdles persist as challenges. Major markets like California, Texas, New York, and Florida lead
Thermo Fisher Scientific Stock: Is TMO Outperforming the Health Care Sector?
Description: Thermo Fisher Scientific has outperformed the broader healthcare sector over the past year, and analysts continue to hold a strongly bullish view on its growth prospects.
2025-11-25
2025-11-24
Are Thermo Fisher Shares a Fair Deal After Key Pharma Partnerships and 14% Price Surge?
Description: Ever wondered if Thermo Fisher Scientific's stock is truly worth its current price? Let's dive into what those numbers may be telling us. The share price has climbed an impressive 14.4% over the past year, with a 12.2% gain so far in 2024. This signals growing investor confidence and possible changes in how the market perceives the company's risks and rewards. Recently, Thermo Fisher has been in the spotlight after expanding partnerships with major pharmaceutical players and making...
Thermo Fisher Scientific Prices Offering of Euro-Denominated Senior Notes
Description: WALTHAM, Mass., November 25, 2025--Thermo Fisher Scientific Inc. (NYSE: TMO) ("Thermo Fisher") announced today that it has priced an offering of €2.1 billion aggregate principal amount (the "Offering") of the following euro-denominated notes, which will be issued by Thermo Fisher Scientific (Finance I) B.V., its indirect, wholly-owned finance subsidiary:
Net Lease Office Properties Declares Special Cash Distribution of $4.10 Per Share
Description: Net Lease Office Properties (NYSE: NLOP) reported today that its Board of Trustees declared a special cash distribution of $4.10 per common share, totaling approximately $60.7 million. The distribution is payable on December 19, 2025 to shareholders of record as of the close of business on December 4, 2025.
Liquid Biopsy Market Competitive Landscape Report 2025: Recent Developments, Strategies, Sustainability Benchmarking, Product Analysis, Key Persons and Revenue
Description: The Liquid Biopsy market is projected to grow robustly from US$ 4.29 Billion in 2024 to US$ 15.46 Billion by 2033, driven by advancements in oncology and precision medicine. This sector benefits from the minimally invasive nature of liquid biopsies, which allow early cancer detection and treatment monitoring through blood samples. Key players like Roche, Exact Sciences, and Thermo Fisher are enhancing their offerings to meet the rising demand. Innovations and regulatory approvals continue to exp
Beat the Market the Zacks Way: Goldman Sachs, Micron, Prelude in Focus
Description: GS stands out as Zacks showcases how its stock picks like MU and PRLD delivered strong gains despite a shaky market.
1 Cash-Producing Stock to Own for Decades and 2 Facing Headwinds
Description: While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.
2025-11-23
2025-11-22
2025-11-21
Why Is Thermo Fisher (TMO) Up 0.2% Since Last Earnings Report?
Description: Thermo Fisher (TMO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Solventum inks $725M Acera takeover
Description: The company has stepped up its interest in M&A since making a $4.1 billion divestiture that strengthened its balance sheet.
2025-11-20
Quanterix Announces Board and Leadership Changes to Support Next Stage of Growth
Description: BILLERICA, Mass., November 20, 2025--Quanterix Corporation ("Quanterix" or the "Company") (NASDAQ: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced a series of leadership and governance enhancements designed to support the Company’s next phase of growth. These changes include the appointment of two highly accomplished life sciences executives, Garret Hampton, Ph.D., and Alan Sachs, M.D., Ph.D., to the Company’s Board
Thermo Fisher Scientific’s Oncomine Dx Target Test Receives FDA Approval as a Companion Diagnostic to Identify Patients Eligible for Newest Targeted Therapy for Non-Small Cell Lung Cancer
Description: CARLSBAD, Calif., November 20, 2025--Thermo Fisher Scientific, the world leader in serving science, has received approval from the U.S. Food and Drug Administration (FDA) for its Ion Torrent™ Oncomine™ Dx Target Test as a companion diagnostic (CDx) to identify patients who may be eligible for treatment with HYRNUO™ (sevabertinib), a new HER2-directed therapy developed and commercialized by Bayer. The test enables clinicians and pathologists to identify non-small cell lung cancer (NSCLC) tumors w
TMO Stock May Rise Post New PCR Test in Collab With Coca-Cola Partner
Description: Thermo Fisher's new all-in-one SureTect qPCR assay promises faster, broader beverage spoilage detection and sharper quality control.
OutSystems Agent Workbench Accelerates Enterprise Agentic AI Adoption
Description: OutSystems, the leading AI-powered low-code development platform, today announced strong early momentum for Agent Workbench, its enterprise-grade platform for building and orchestrating intelligent AI agents across data sets, workflows, or systems. Following its general availability launch on September 30, enterprises across industries are already using Agent Workbench to accelerate agentic transformation, moving from pilots to production and orchestrating multi-agent workflows with built-in hum
2025-11-19
The Bull Case For Thermo Fisher Scientific (TMO) Could Change Following EXENT System Clearance and New Philly Center Opening – Learn Why
Description: Thermo Fisher Scientific recently received U.S. 510(k) clearance for its EXENT System, an automated analyser aimed at improving the diagnosis of multiple myeloma, and announced the grand opening of its East Coast Advanced Therapies Collaboration Center in Philadelphia to support cell and gene therapy innovation. These milestones expand Thermo Fisher's expertise in diagnostics and advanced therapies, providing researchers and clinicians with new tools and infrastructure to accelerate...
OutSystems Agent Workbench Accelerates Enterprise Agentic AI Adoption
Description: MIAMI, November 19, 2025--OutSystems, the leading AI-powered low-code development platform, today announced strong early momentum for Agent Workbench, its enterprise-grade platform for building and orchestrating intelligent AI agents across data sets, workflows, or systems. Following its general availability launch on September 30, enterprises across industries are already using Agent Workbench to accelerate agentic transformation, moving from pilots to production and orchestrating multi-agent w
Thermo Fisher Scientific Launches Industry-First, Multi-Parameter Molecular Assay for Rapid Beverage Quality Testing*
Description: WALTHAM, Mass., November 19, 2025--To support the quality of beverage products, Thermo Fisher Scientific today introduced the Thermo Scientific™ SureTect™ Beverage Spoilage Multiplex qPCR Assay**, an industry-first all-in-one quantitative Polymerase Chain Reaction (PCR)-based test developed in collaboration with Coca-Cola Europacific Partners. Now part of the Thermo Scientific SureTect PCR System, the assay offers early and accurate detection of spoilage organisms earlier in the production proce
2025-11-18
Real-time data: how to gain an edge amid clinical services consolidation
Description: Amanda Murphy, senior director at GlobalData shares how companies can ensure success amidst consolidation in the clinical services sector.
2025-11-17
Thermo Fisher Scientific Launches CorEvitas Clinical Registry in Myasthenia Gravis, a Rare Autoimmune Disorder
Description: WALTHAM, Mass., November 17, 2025--Thermo Fisher Scientific Inc., the world leader in serving science, today announced the enrollment of the first patient in the new PPD™ CorEvitas™ Myasthenia Gravis (MG) Registry. This nationwide registry will collect data from MG patients across the United States to study and evaluate existing and emerging MG therapies, tracking health conditions, safety issues, medication usage and overall treatment effectiveness. By leveraging real-world data, the registry w
2025-11-16
2025-11-15
2025-11-14
The Zacks Analyst Blog Highlights NVIDIA, Micron Technology and Thermo Fisher Scientific
Description: Zacks spotlights NVIDIA, Micron and Thermo Fisher in its latest Analyst Blog, highlighting AI-driven tailwinds, memory-market momentum and ongoing innovation across life sciences.
If You Invested $1000 in Thermo Fisher Scientific 10 Years Ago, This Is How Much You'd Have Now
Description: Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
Recombinant Human Fibroblast Growth Factor Global Market Forecast 2025-2030: Markets Benefit from Strategic Investments and Collaborations
Description: Recombinant human fibroblast growth factors offer growth prospects in regenerative medicine and cosmetics, driven by efficient production systems. Key opportunities arise from applications in wound healing, tissue engineering, and cosmetics. Notable firms include Thermo Fisher and Merck.Dublin, Nov. 14, 2025 (GLOBE NEWSWIRE) -- The "Recombinant Human Fibroblast Growth Factor Market - Global Forecast 2025-2030" report has been added to ResearchAndMarkets.com's offering. Recombinant human fibrobla
Thermo Fisher Scientific Digital Transformation Strategy Analysis Report 2025: Digital Transformation and Innovation Strategy, Technology Initiatives, Investments, and Acquisitions
Description: Thermo Fisher presents market opportunities through digital transformation, innovation programs, and strategic tech initiatives. They leverage partnerships, product launches, and acquisitions across segments like Life Sciences, Analytical Instruments, and Diagnostics, aiding pharmaceuticals, research, and healthcare sectors.Dublin, Nov. 14, 2025 (GLOBE NEWSWIRE) -- The "Enterprise Tech Ecosystem Series: Thermo Fisher Scientific - 2025" company profile has been added to ResearchAndMarkets.com's o
Thermo Fisher Scientific (TMO): Assessing Valuation After a 10% Monthly Share Price Surge
Description: Thermo Fisher Scientific (TMO) has caught investors’ attention lately as its shares climbed more than 10% over the past month. The company’s strong recent momentum has some market watchers reassessing its long-term prospects. See our latest analysis for Thermo Fisher Scientific. After a period of sluggishness earlier this year, Thermo Fisher Scientific's 10% share price surge over the past month stands out. This supports a positive year-to-date gain and helps lift its one-year total...
2025-11-13
Top Research Reports for NVIDIA, Micron Technology & Thermo Fisher
Description: NVIDIA, Micron Technology and Thermo Fisher lead today's top analyst picks, each showing strong growth trends and strategic advances.
Hologic Expands European Reach of Genius Digital Diagnostics System
Description: HOLX gains expanded CE marking for its Genius Digital Diagnostics System, enabling imaging of both cell and tissue specimens on one platform.
Are Wall Street Analysts Predicting Thermo Fisher Scientific Stock Will Climb or Sink?
Description: Thermo Fisher Scientific has underperformed the broader market over the past year, but analysts are highly optimistic about the stock’s prospects.
2025-11-12
Devyser Diagnostics AB (FRA:OL0) Q3 2025 Earnings Call Highlights: Record Sales and Strategic ...
Description: Devyser Diagnostics AB (FRA:OL0) reports a 20% sales growth and strong cash position, while navigating distributor sales decline and profitability hurdles.
Enterprises Are Adopting Data and Governance Frameworks and Talent Strategies for Agentic AI, ISG Says
Description: STAMFORD, Conn., November 12, 2025--Enterprise leaders will join the ISG AI Impact Summit, November 17–18 in New York, to discuss adopting, scaling and governing AI business solutions.
Thermo Fisher Scientific Receives 510(k) Clearance in the United States for EXENT System* to Aid in the Diagnosis of Multiple Myeloma
Description: WALTHAM, Mass., November 12, 2025--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced 510(k) clearance of the EXENT® Analyser and Immunoglobulin Isotypes (GAM) Assay**, a first-of-its-kind automated platform for clinical laboratories. The EXENT System combines enhanced sensitivity and automation to provide accurate results, helping clinicians make a fast diagnosis for patients with multiple myeloma and related disorders.
2025-11-11
2025-11-10
Implied Volatility Surging for Thermo Fisher Stock Options
Description: Investors need to pay close attention to TMO stock based on the movements in the options market lately.
Beat the Market the Zacks Way: Amgen, Ciena, Fair Isaac in Focus
Description: Amgen, Ciena, and Fair Isaac shine as Zacks' proven stock-ranking strategies continue to outperform amid market uncertainty.
2025-11-09
2025-11-08
2025-11-07
Thermo Fisher Unveils $5 Billion Buyback, Keeps Dividend Intact
Description: The life sciences giant signals confidence with a massive repurchase plan and steady shareholder payouts
Thermo Fisher Scientific Inc.'s (NYSE:TMO) Stock Is Going Strong: Have Financials A Role To Play?
Description: Thermo Fisher Scientific (NYSE:TMO) has had a great run on the share market with its stock up by a significant 23% over...
2025-11-06
Thermo Fisher Scientific Authorizes $5 Billion of Share Repurchases
Description: WALTHAM, Mass., November 06, 2025--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors has authorized the repurchase of $5 billion of shares of its common stock in the open market or in negotiated transactions. The authorization has no expiration date.
Thermo Fisher Scientific Declares Quarterly Dividend
Description: WALTHAM, Mass., November 06, 2025--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors authorized a quarterly cash dividend of $0.43 per common share, payable on January 15, 2026, to shareholders of record as of December 15, 2025.
Diamond Hill Capital Large Cap Fund Added Thermo Fisher Scientific (TMO) on a Dip
Description: Diamond Hill Capital, an investment management company, released its “Large Cap Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. Markets continued their YTD rally in the third quarter of 2025, with the Russell 3000 Index gaining 8%, bringing the calendar-year returns to over 14%. The portfolio declined and underperformed the […]
2025-11-05
2025-11-04
Cas12 Protein Market Report 2025: Market Led by Thermo Fisher, Bio-Techne and IDT, With APAC Set for Fastest Growth Despite Trade-Driven Supply Challenges - Global Forecast to 2029 and 2034
Description: Key market opportunities for Cas12 proteins include rising government investments in biotech, increased demand for diagnostics in developing regions, growing integration into sequencing platforms, gene-editing advancements, and expanding applications in personalized medicine and agricultural biotechnology. Cas12 Protein Market Cas12 Protein Market Dublin, Nov. 04, 2025 (GLOBE NEWSWIRE) -- The "Cas12 Protein Market Report 2025" has been added to ResearchAndMarkets.com's offering. The Cas12 Protei
Methyl Acetate Industry Research and Global Forecast Report 2025-2030: Lucrative Opportunities in Expanding Applications Across High-Growth Industries, & Growth Through Bio-based and Circular Economy
Description: The global methyl acetate market is projected to grow from USD 228.0 million in 2025 to USD 388.5 million by 2030, at a CAGR of 7.9%. This growth is driven by its fast-evaporating, low-toxicity advantages, making it a preferred solvent in paints, coatings, adhesives, pharmaceuticals, and electronics. With increasing VOC regulations from environmental bodies like the EPA and ECHA, manufacturers are innovating by offering sustainable, high-purity variants. Asia Pacific leads the market, supported
2025-11-03
Here’s Why Baron Health Care Fund Added Thermo Fisher Scientific (TMO) to Its Portfolio
Description: Baron Funds, an investment management company, released its “Baron Health Care Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund rose 5.39% (Institutional Shares) in the quarter, compared to a 5.05% gain for the Russell 3000 Health Care Index (benchmark) and an 8.18% gain for the Russell 3000 […]
2025-11-02
Investors in Thermo Fisher Scientific (NYSE:TMO) have seen returns of 15% over the past three years
Description: Low-cost index funds make it easy to achieve average market returns. But in any diversified portfolio of stocks, you'll...
2025-11-01
2025-10-31
2025-10-30
Biodesix to Share its R&D Roadmap during its Corporate Day Presentation at AMP Annual Meeting
Description: Speaker panel will include collaborative case study presentations from strategic partners: Memorial Sloan Kettering Cancer Center, Bio-Rad Laboratories, and Thermo Fisher ScientificLOUISVILLE, Colo., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostics solutions company, announces its Corporate and Scientific presentations, and exhibitor presence at the 2025 AMP Annual Meeting, November 12-15, in Boston, MA. BIODESIX WORKSHOP: On November 12, at 4:00 ET, Dr. Gar
2025-10-29
Sector Update: Health Care Stocks Fall Late Afternoon
Description: Health care stocks were lower late Wednesday afternoon, with the NYSE Health Care Index decreasing 0
Sector Update: Health Care Stocks Softer Wednesday Afternoon
Description: Health care stocks were lower Wednesday afternoon, with the NYSE Health Care Index easing 0.1% and t
Thermo Fisher to buy Clario for $8.8bn
Description: The completion of the acquisition is anticipated by mid-2026, pending the satisfaction of customary closing conditions.
If You Invested $1000 in Thermo Fisher Scientific a Decade Ago, This is How Much It'd Be Worth Now
Description: Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.
Does Thermo Fisher's 20% Rally Signal More Upside After New Pharma Partnerships?
Description: If you are watching Thermo Fisher Scientific right now and wondering what your next move should be, you are not alone. This stock has been on quite a journey lately, making it a hot topic for investors seeking growth or reassessing risk. Over the past month, Thermo Fisher shares have surged 20.1%, a noticeable rally that follows a steadier 6.7% gain year-to-date and a modestly positive 2.2% return over the past year. Recently, there has been increased investor confidence, partly sparked by...
Thermo Fisher to acquire clinical trial data firm Clario for $8.9B
Description: The purchase is expected to complement Thermo’s clinical research services, as companies are conducting more trials.
Thermo Fisher Scientific Agrees to Buy Clario Holdings for $8.88 Billion
Description: Thermo Fisher Scientific agreed to acquire endpoint data solutions provider Clario Holdings from a shareholder group for $8.88 billion in cash.
Thermo Fisher Scientific to Acquire Clario Holdings, Inc., Enabling Pharma and Biotech Customers to Accelerate Innovation with Deeper Clinical Insights
Description: WALTHAM, Mass., October 29, 2025--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced a definitive agreement to acquire Clario Holdings, Inc., a leading provider of endpoint data solutions for clinical trials, from a shareholder group led by Astorg and Nordic Capital, Novo Holding and Cinven, for $8.875 billion in cash at close plus potential additional earnout and other payments in the future, largely dependent on performance.
5 Revealing Analyst Questions From Thermo Fisher’s Q3 Earnings Call
Description: Thermo Fisher's third quarter results drew a positive market response, with management attributing outperformance to robust momentum in bioproduction, analytical instruments, and clinical research businesses. CEO Marc Casper highlighted the successful integration of recent acquisitions and an active capital deployment strategy as core contributors. The company also benefited from operational execution and productivity improvements, particularly through its Practical Process Improvement (PPI) bus
2025-10-28
[Latest] Global Airport Cabin Baggage Scanner Market Size/Share Worth USD 7.5 Billion by 2034 at a 9.8% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
Description: [220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Airport Cabin Baggage Scanner Market size & share revenue was valued at approximately USD 3.2 Billion in 2024 and is expected to reach USD 3.5 Billion in 2025 and is expected to reach around USD 7.5 Billion by 2034, at a CAGR of 9.8% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Leidos, L3Harris Techn
Thermo Fisher Scientific Enables Semiconductor Manufacturers to See the Unseen with Helios MX1 PFIB-SEM
Description: WALTHAM, Mass., October 28, 2025--From smartphones to autonomous cars to AI supercomputers, nearly every electronic innovation we use today depends on complicated structures at the atomic scale within silicon chips. As these chips increase in processing power and decrease in size, even the smallest fault can cause massive delays.
2025-10-27
Beat the Market the Zacks Way: PDD, Shopify, 3M in Focus
Description: Zacks showcases how its proven strategies and model portfolios continue to outperform, with PDD, Shopify and 3M among standout performers across portfolios.
Thermo Fisher Scientific Showcases Enhanced Accelerator™ Drug Development Capabilities and OpenAI Strategic Collaboration at CPHI Frankfurt 2025
Description: FRANKFURT, Germany, October 27, 2025--Thermo Fisher Scientific Inc., the world leader in serving science, will showcase its latest flexible solutions to help boost efficiency and scale in biopharmaceutical manufacturing at every stage of drug development during CPHI Frankfurt 2025 (October 28–30, booth #5.1A8, Hall 5.1). Leaders from across the organization will participate in a series of panel discussions highlighting industry trends, sustainability strategies and how collaboration can accelera
2025-10-26
2025-10-25
Jim Cramer on Thermo Fisher: “Maybe This Stock Can Finally Get its Groove Back”
Description: Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the stocks Jim Cramer put under the spotlight recently. Cramer discussed the company’s latest earnings, as he commented: “So what do we make of these numbers from Thermo Fisher Scientific, a company I’ve liked for so long? It’s a big life sciences company, reported better than expected […]
2025-10-24
2025-10-23
Earnings live: Intel stock surges, Ford rises after-hours, Deckers drops
Description: Third quarter earnings season is ramping up, and analysts expect S&P 500 companies grew their profits by 8% during the quarter.
Thermo Fisher Scientific Launches Industry-First Orbitrap Mass Detector for Environmental and Food Safety Testing
Description: WALTHAM, Mass., October 23, 2025--Thermo Fisher Scientific, the world leader in serving science, today introduced the Thermo Scientific™ Orbitrap Exploris™ EFOX Mass Detector, the industry’s first high-resolution accurate mass (HRAM) Orbitrap system designed specifically for environmental and food safety laboratories. The new system addresses urgent global challenges around food and water quality testing in the face of persistent contaminants, such as per- and polyfluoroalkyl substances (PFAS),
Thermo Fisher Scientific (TMO): Assessing Valuation After Upbeat Q3 Results and Raised Outlook
Description: Thermo Fisher Scientific (TMO) just posted third-quarter results that came in ahead of expectations, showing healthy revenue growth and a raised full-year outlook. Investors are watching how recent partnerships and innovation continue to fuel that momentum. See our latest analysis for Thermo Fisher Scientific. Thermo Fisher’s upbeat quarter arrives on the back of some exciting moves, from launching cutting-edge microarray technology to rolling out new AI collaborations in drug development...
TMO Q3 Deep Dive: New Products, Capital Deployment, and Strategic Collaborations Drive Growth
Description: Life sciences company Thermo Fisher (NYSE:TMO) reported revenue ahead of Wall Street’s expectations in Q3 CY2025, with sales up 4.9% year on year to $11.12 billion. Its non-GAAP profit of $5.79 per share was 5.3% above analysts’ consensus estimates.
2025-10-22
Bank of America Securities Reiterates a Buy Rating on Thermo Fisher Scientific (TMO)
Description: Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the best long term low volatility stocks to buy right now. On October 20, Bank of America Securities analyst Michael Ryskin reiterated a Buy rating on Thermo Fisher Scientific Inc. (NYSE:TMO), without assigning a price target. The rating update followed Thermo Fisher Scientific Inc.’s (NYSE:TMO) announcement on […]
Earnings live: Tesla stock falls after earnings miss, IBM sinks
Description: Third quarter earnings season is ramping up, and analysts expect S&P 500 companies grew their profits by 8% during the quarter.
Thermo Fisher Scientific Inc (TMO) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ...
Description: Thermo Fisher Scientific Inc (TMO) reports robust financial performance with a 5% revenue increase and upwardly revised 2025 guidance, despite facing headwinds in certain sectors.
Sector Update: Health Care Stocks Higher Wednesday Afternoon
Description: Health care stocks rose Wednesday afternoon, with the NYSE Health Care Index up 0.6% and the Health
Pre-Market Futures Flat at This Hour
Description: Pre-Market Futures Flat at This Hour.
Thermo Fisher Scientific Lifts 2025 Outlook Following Third-Quarter Beat
Description: Thermo Fisher Scientific (TMO) raised its full-year outlook on Wednesday as the medical-device manuf
Q3 Earnings Bonanza Pulls a Flat Pre-Market: T, TMO, TSLA, etc.
Description: Q3 earnings reports released yesterday afternoon did not quite have the positive sheen we've seen elsewhere this far into earnings season.
Compared to Estimates, Thermo Fisher (TMO) Q3 Earnings: A Look at Key Metrics
Description: While the top- and bottom-line numbers for Thermo Fisher (TMO) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Thermo Fisher's Q3 Earnings & Revenues Top Estimates, Stock Climbs
Description: TMO delivers robust Q3 results, fueled by margin growth, new launches and AI-focused strategic initiatives.
Traders Eye Tesla Earnings, Geopolitical News as US Equity Futures Waver Pre-Bell
Description: US equity futures were flat ahead of Wednesday's opening bell as traders looked ahead to earnings fr
Stocks Down Pre-Bell as Trump Signals Xi Jinping Meeting May Not Happen; Tesla Earnings on Deck
Description: The main US stock measures were trending lower in Wednesday's premarket activity as President Donald
Thermo Fisher Scientific (TMO) Beats Q3 Earnings and Revenue Estimates
Description: Thermo Fisher (TMO) delivered earnings and revenue surprises of +5.27% and +1.99%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Thermo Fisher Scientific beats Q3 expectations as revenue rises 5%
Description: Investing.com -- Thermo Fisher Scientific Inc. (NYSE:TMO) reported third-quarter results that exceeded analyst expectations, with adjusted earnings per share and revenue both surpassing consensus estimates. Shares of the scientific equipment maker rose 1.4% following the announcement.
Thermo Fisher Scientific Fiscal Q3 Adjusted Earnings, Revenue Rise; Shares Up Pre-Bell
Description: Thermo Fisher Scientific (TMO) reported fiscal Q3 adjusted earnings Wednesday of $5.79 per diluted s
Thermo Fisher: Q3 Earnings Snapshot
Description: WALTHAM, Mass. AP) — Thermo Fisher Scientific Inc. TMO) on Wednesday reported third-quarter earnings of $1.62 billion.
Thermo Fisher (NYSE:TMO) Surprises With Q3 Sales
Description: Life sciences company Thermo Fisher (NYSE:TMO) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 4.9% year on year to $11.12 billion. Its non-GAAP profit of $5.79 per share was 5.3% above analysts’ consensus estimates.
Thermo Fisher Scientific Reports Third Quarter 2025 Results
Description: WALTHAM, Mass., October 22, 2025--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the third quarter ended September 27, 2025.
Tesla Earnings, Inflation Data: What to Watch Over the Rest of This Week
Description: The U.S. government shutdown continues, but investors won't be completely starved for economic data. Friday brings a delayed look at September’s consumer-price index, a key inflation reading that will factor into the Federal Reserve’s next decision on interest rates.
2025-10-21
Earnings live: GM stock soars, Netflix sinks as third quarter results pour in
Description: Third quarter earnings season is ramping up, and analysts expect S&P 500 companies grew their profits by 8% during the quarter.
Thermo Fisher Scientific Launches Innovative Carbon Calculator to Drive Greener Clinical Trials
Description: WILMINGTON, N.C., October 21, 2025--Thermo Fisher Scientific Launches Innovative Carbon Calculator to Drive Greener Clinical Trials
Leading Companies in Bioseparation Systems Market: Strategies and Innovations Explored
Description: The bioseparation systems market offers growth opportunities driven by increasing biopharmaceutical demands, particularly in emerging markets like Japan and the Pacific Rim. Key methods like chromatography play a crucial role in drug development. Major players include Thermo Fisher and Sartorius. Separation Systems for Commercial Biotechnology Market Separation Systems for Commercial Biotechnology Market Dublin, Oct. 21, 2025 (GLOBE NEWSWIRE) -- The "Separation Systems for Commercial Biotechnolo
Inflation Data; Intel and Tesla Earnings: What to Watch This Week
Description: The U.S. government shutdown continues, but investors won't be completely starved for economic data. Friday brings a delayed look at September’s consumer-price index, a key inflation reading that will factor into the Federal Reserve’s next decision on interest rates.
2025-10-20
Thermo Fisher (TMO) Reports Q3: Everything You Need To Know Ahead Of Earnings
Description: Life sciences company Thermo Fisher (NYSE:TMO) will be announcing earnings results this Wednesday morning. Here’s what investors should know.
Earnings live: Cleveland-Cliffs stock soars, Zions Bancorp rises with results from GM, Netflix on deck
Description: Third quarter earnings season is ramping up, and analysts expect S&P 500 companies grew their profits by 8% during the quarter.
Inflation Data; Intel and Tesla Earnings: What to Watch This Week
Description: The U.S. government shutdown is set to drag into another week, but that doesn’t mean investors will be starved for economic data. Friday brings a delayed look at September’s consumer-price index, a key inflation reading that will factor into the Federal Reserve’s next decision on interest rates.
2025-10-19
Tesla, Netflix set to report earnings as US-China trade fight turns 'unsustainable': What to watch this week
Description: As investors enters shutdown week three, a US-China trade war, credit gesticulation, and an incoming oil glut are weighing on the market.
2025-10-18
2025-10-17
Inflation Data, Intel and Tesla Earnings: What to Watch Next Week
Description: The U.S. government shutdown is set to drag into another week, but that doesn’t mean investors will be starved for economic data. Next Friday brings a (delayed) look at September’s consumer-price index, a key inflation reading that will factor into the Federal Reserve’s next decision on interest rates.
What Thermo Fisher Scientific (TMO)'s OpenAI Partnership Could Mean for Drug Development Innovation
Description: Thermo Fisher Scientific recently announced a collaboration with OpenAI to integrate advanced artificial intelligence into its Accelerator Drug Development solution, aiming to enhance the speed and success rate of drug development for its customers. This partnership highlights the growing role of AI in accelerating clinical trials and streamlining therapeutic discovery, positioning Thermo Fisher Scientific at the forefront of digital transformation in the life sciences industry. We'll...
Countdown to Thermo Fisher (TMO) Q3 Earnings: Wall Street Forecasts for Key Metrics
Description: Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Thermo Fisher (TMO), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2025.
Intuitive Surgical Pre-Q3 Analysis: Buy, Hold or Sell ISRG Stock Now?
Description: Intuitive Surgical enters Q3 earnings season on strong momentum, backed by robust procedure growth and da Vinci 5 adoption. However, tariff risks and global CapEx constraints remain challenges.